申请人:Purdue Pharma L.P.
公开号:US20140249128A1
公开(公告)日:2014-09-04
The present disclosure provides substituted triazine carboxamides of Formula I:
and the pharmaceutically acceptable salts and solvates thereof, wherein A
1
, X, A
2
, E, and Z are defined as set forth in the specification. The present disclosure is also directed to the use of compounds of Formula I to treat a disorder responsive to the blockade of sodium channels. Compounds of the present disclosure are especially useful for treating pain.
本公开提供了式I的替代三嗪羧酰胺化合物:和其药用可接受的盐和溶剂,其中A1、X、A2、E和Z的定义如规范中所述。本公开还涉及使用式I的化合物来治疗对钠通道阻滞有响应的疾病。本公开的化合物特别适用于治疗疼痛。